Literature DB >> 3439816

Dust exposures at U.S. surface coal mines in 1982-1983.

H E Amandus1, G Piacitelli.   

Abstract

Exposures to British Mining Research Establishment corrected respirable dust and respirable quartz at U.S. surface coal mines during 1982-1983 were evaluated from coal mine operator and Mine Safety and Health Administration (MSHA) inspector samples. The average respirable quartz concentration from inspector samples ranged from .34-.49 mg/m3 for drilling jobs and .18 mg/m3 for bulldozer operators. For most other surface coal mine jobs, the average respirable quartz concentration was less than .1 mg/m3, and the average respirable dust concentration was less than 2 mg/m3. The results from the analysis of quartz exposures are consistent with epidemiological results for an increased silicosis risk among drillers. It is unclear, however, whether the MSHA samples provide a representative estimate of the average annual quartz concentration for drillers. Results suggest the need for a greater number of quartz samples to be taken on strip coal miners, particularly on drillers and bulldozer operators.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3439816     DOI: 10.1080/00039896.1987.9934362

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  3 in total

1.  Mortality of iron miners in Lorraine (France): relations between lung function and respiratory symptoms and subsequent mortality.

Authors:  N Chau; L Benamghar; Q T Pham; D Teculescu; E Rebstock; J M Mur
Journal:  Br J Ind Med       Date:  1993-11

2.  Respiratory health effects of opencast coalmining: a cross sectional study of current workers.

Authors:  R G Love; B G Miller; S K Groat; S Hagen; H A Cowie; P P Johnston; P A Hutchison; C A Soutar
Journal:  Occup Environ Med       Date:  1997-06       Impact factor: 4.402

3.  Respirable coal mine dust at surface mines, United States, 1982-2017.

Authors:  Brent C Doney; David Blackley; Janet M Hale; Cara Halldin; Laura Kurth; Girija Syamlal; A Scott Laney
Journal:  Am J Ind Med       Date:  2019-12-09       Impact factor: 3.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.